Guidance Document - E10: Choice of Control Group and Related Issues in Clinical Trials

Guidance Document - E10: Choice of Control Group and Related Issues in Clinical Trials This guidance was developed by the appropriate ICH Expert Working Group and was subject to consultation by the regulatory parties, in accordance with the ICH Process. ICH E10 has been implemented by the regulatory bodies of the United States, European Union, Japan, Switzerland and Australia. 2023-12-02 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyguidance documentE10choice of control-groupclinical trials Guidance Document - E10: Choice of Control Group and Related Issues in Clinical TrialsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/choice-control-group-related-issues-clinical-trials-topic.html Guidance Document - E10: Choice of Control Group and Related Issues in Clinical TrialsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/international-conference-harmonisation/efficacite/choix-groupe-temoin-questions-connexes-cadre-essais-cliniques-theme.html

This guidance was developed by the appropriate ICH Expert Working Group and was subject to consultation by the regulatory parties, in accordance with the ICH Process. ICH E10 has been implemented by the regulatory bodies of the United States, European Union, Japan, Switzerland and Australia.

Data and Resources

Similar records